Muutke küpsiste eelistusi

Socio-Technological Relationships in Vaccine Systems: Uncovering the Dynamics of Interaction [Kõva köide]

Edited by , Edited by
  • Formaat: Hardback, 301 pages, kõrgus x laius: 210x148 mm, 5 Illustrations, color; 2 Illustrations, black and white
  • Ilmumisaeg: 11-Jun-2026
  • Kirjastus: Palgrave Macmillan
  • ISBN-10: 9819583489
  • ISBN-13: 9789819583485
  • Kõva köide
  • Hind: 83,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 111,99 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Socio-Technological Relationships in Vaccine Systems: Uncovering the Dynamics of Interaction
  • Formaat: Hardback, 301 pages, kõrgus x laius: 210x148 mm, 5 Illustrations, color; 2 Illustrations, black and white
  • Ilmumisaeg: 11-Jun-2026
  • Kirjastus: Palgrave Macmillan
  • ISBN-10: 9819583489
  • ISBN-13: 9789819583485
This book critically examines the foundational assumptions of vaccine systems, challenging the dominant linear narrative of vaccine creation and production, regulation, and distribution. Rather than treating these components as isolated and sequential, the project adopts a holistic approach to unpack their dynamic interrelations. The volume is organized into three partsCreation and Production, Regulation, and Distributioneach showcasing how broader social, political, cultural, and economic processes shape the inter-relationships between these components.



It offers a unique contribution by reframing the understanding of vaccine systems through an interdisciplinary lens that draws on law, public health, innovation studies, psychology and science and technology studies. It is distinct in combining theoretical analysis with empirical insights from diverse national and socio-cultural contexts to examine how these systems operate in practice. In doing so, it supports the call for more inclusive, transparent, and context-sensitive models of vaccine governance, which is particularly important in the aftermath of the COVID-19 pandemic and in preparation for future public health challenges.
Introduction: Socio-Technological relationships in Vaccine Systems:
Innovation, Production, Distribution and Equity.- Part-I. Creation and
Production.
Chapter 1: Vaccine innovation histories through socio
technological lens.
Chapter 2: Timing the Valve: How Does Intellectual
Property Impact on Early Market Entry for mRNA Vaccines in Australia to
Promote Vaccine Equity?.
Chapter 3: Local Vaccine Production in Australia:
Industrial Development and Access Considerations.
Chapter 4: Vaccine
Technology Platforms, Market Structures, Intellectual Property Regimes, and
Local Production.- PART II: REGULATION.
Chapter 5: Ambivalent Safeties:
Attending to Intersectional Marginalities in Vaccine Pharmacovigilance.-
Chapter 6: Assembling a New Vaccine Ecosystem: Rethinking Responsibility and
Vaccine Security After the Crisis.
Chapter 7: A regulatory vacuum and its
consequences for public trust in vaccines: Cautionary tale from India.- PART
III: DISTRIBUTION AND EQUITY.
Chapter 8: Vaccine Demand: Theory and Evidence
on Psychological and Social Drivers.
Chapter 9: Synthesising Vaccine
Hesitancy Research: A Bibliometric Analysis and Structured Review.
Chapter
10: Bridging the Last Mile: Using PrEP Implementation Insights to Shape
Africas HIV Vaccine Preparedness.
Chapter 11: Mapping Vaccine Manufacturing
and Pooled Procurement Initiatives in Africa.
Omkar P. Nadh is an interdisciplinary Research Fellow at the T.C. Beirne School of Law, University of Queensland, working in the field of science technology society studies (STS). His research examines healthcare biotechnological innovation  with particular attention to their politicaleconomic dynamics and public health implications.





Tolulope Adekola is a Lecturer in Law at the Australian Catholic University. Tolulope's expertise is in intellectual property law and public health law. His research focuses on the role of intellectual property law in vaccine development and distribution. More generally, he is interested in issues pertaining to facilitating access to vaccines and other medical technologies on equitable and affordable terms.